Armstrong Advisory Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Armstrong Advisory Group's DGX Position: Q3 2026 in Review
Armstrong Advisory Group held its Quest Diagnostics (DGX) position steady in Q3 2026 at 54 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #670.
Armstrong Advisory Group first reported a position in DGX in Q4 2022 and has held it in 16 quarters since. 266 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Armstrong Advisory Group held 54 shares of Quest Diagnostics worth $12.6K as of Q3 2026.
- Armstrong Advisory Group left its Quest Diagnostics share count unchanged in Q3 2026.
- Quest Diagnostics made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #670 holding.
- Armstrong Advisory Group first reported a position in Quest Diagnostics in Q4 2022 and has held it in 16 quarters since.
- 266 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.